Aman Chauhan, Leader of Neuroendocrine Cancer Program at the Sylvester Comprehensive Cancer Center, shared a post on X:
“Well, it’s that time of the year again! Pumpkin Spice Latte season, Christmas playlists around the corner – and best of all, time to wrap up an incredibly exciting 2025 with ESMO, NANETS, and SNMMI! At ESMO, we’re presenting data from our investigator-initiated, multi-center Phase I study of Triapine + Lu-177 dotatate – the foundation for an ongoing randomized Phase II trial. Proud moment for the team!
At NANETS, we’ll be recording a new podcast series featuring hot topics and inspiring guests from the NET community. Stay tuned!
At SNMMI, our focus will be on bridging Nuclear Medicine, Radiation Oncology, and Medical Oncology – advancing the shared goal of efficient and rational radiopharmaceutical drug development. Tremendous progress, but still so much more to achieve. Easily one of the strongest SNMMI agendas to date.”
More posts featuring Aman Chauhan.